​
​

DICE Therapeutics Ownership | Who Owns DICE Therapeutics?

OverviewForecastChart

DICE Therapeutics Ownership Summary

DICE Therapeutics is owned by 96.64% institutional investors, and 3.36% retail investors. Vanguard Instl Ttl Stck Mkt Idx Tr is the top mutual fund, with 2.33% of its assets in DICE Therapeutics shares.

DICE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockDICE Therapeutics96.64%-3.36%
SectorHealthcare Stocks 46.62%8.13%45.25%
IndustryBiotech Stocks 44.91%7.98%47.11%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202318254.24%45,608,375-12.42%960.79%12093.55%346.25%
Mar 31, 20231186.31%52,079,1139.72%1101.01%62-26.19%3252.38%
Dec 31, 202211115.63%47,464,77528.66%1041.08%8475.00%2110.53%
Sep 30, 20229621.52%36,891,3071.31%981.04%48-1911.76%
Jun 30, 2022792.60%36,413,2249.17%971.22%4811.63%17-26.09%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Instl Ttl Stck Mkt Idx Tr1.11M2.33%-1.28K
The Merger Fund A761.14K1.59%761.14K
NexPoint Merger Arbitrage Z683.26K1.43%683.26K
FIAM Small Cap Core Composite385.00K0.81%-39.40K
Fidelity® Small Cap Index345.87K0.72%5.03K
Picton Mahoney Fortified Arbtrg Pl Alt F256.50K0.54%256.50K
First Trust Merger Arbitrage Cl I246.22K0.52%246.22K
FIAM Small Cap Core CIT Cl B195.42K0.41%-189.58K
Meridian Small Cap Growth Legacy166.50K0.35%-
NT R2000 Index Fund - NL110.40K0.23%9.34K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 22, 2023Northpond Ventures GP, LLC-Sell$24.34M
Jun 22, 2023Northpond Ventures GP, LLC-Sell$91.58M
Jun 01, 2023Jacobsen John R. CSOSell$433.65K
Jun 01, 2023Jacobsen John R. CSOSell$138.80K
May 05, 2023SCHELLER RICHARD H-Sell$3.24M

Insider Transactions Trends

DateBuySell
2023 Q3--
2023 Q2-9
2023 Q164
2022 Q41-
2022 Q2--

DICE Ownership FAQ

Who Owns DICE Therapeutics?

DICE Therapeutics shareholders are primarily institutional investors at 96.64%, followed by 0% insiders and 0% retail investors. The average institutional ownership in DICE Therapeutics's industry, Biotech Stocks , is 44.91%, which DICE Therapeutics exceeds.

Does Blackrock own DICE Therapeutics?

BlackRock is not among the top 10 institutional shareholders of DICE Therapeutics.

Who is the top mutual fund holder of DICE Therapeutics shares?

Vanguard Instl Ttl Stck Mkt Idx Tr is the top mutual fund holder of DICE Therapeutics shares, with 2.33% of its total shares outstanding invested in 1.11M DICE Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools